A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BeOne Medicines
Children's Oncology Group
The Second Affiliated Hospital of Hainan Medical University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Jiangxi Provincial People's Hopital
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Beijing Tongren Hospital
VA Office of Research and Development
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
Regeneron Pharmaceuticals
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Baptist Health South Florida
Children's Oncology Group
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Emory University
Regeneron Pharmaceuticals
Washington University School of Medicine
Massachusetts General Hospital
M.D. Anderson Cancer Center
Children's Oncology Group
Sanofi
H. Lee Moffitt Cancer Center and Research Institute
Sanofi
Barbara Ann Karmanos Cancer Institute
Sumitomo Pharma America, Inc.
University of Liverpool
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Oncotherapeutics
Oncotherapeutics
Sun Yat-sen University
Universitätsklinikum Hamburg-Eppendorf
University of Colorado, Denver
Children's Oncology Group
Columbia University
Gilead Sciences
Ipsen
University of Nebraska
Oncotherapeutics